Clopidorel-based antiplatelet therapy is not enough for stent patency in patients undergoing femoropopliteal arterial endovascular interventions.

25 August 2018 (00:00 - 00:00)

Organised by:

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Kensaku Higashi

National Hospital Organization Kagoshima Medical Center, Kagoshima (Japan)

9 More presentations in this session

Presentation thumbnail

Outcome of spot versus full-coverage nitinol stenting after endovascular therapy for femoropopliteal artery disease

Doctor Y. Tomoi (Kitakyushu, JP)

Presentation thumbnail

Impact of baseline characteristics on efficacy of cilostazol for patients performing endovascular therapy for femoropopliteal lesions

Doctor S. Hiramori (Kitakyushu, JP)

Abstract Slides

Presentation thumbnail

Long term usefulness of target lesion revascularization for asymptomatic restenosis of superficial femoral artery after endovascular therapy

Doctor M. Utsunomiya (Tokyo, JP)

Presentation thumbnail

Comparison of transradial vs transfemoral access for iliac, femoral, and popliteal interventions. A single-center experience

Associate Professor Z. Ruzsa (Szeged, HU)

Abstract Slides

Presentation thumbnail

Predictive value of vessel size for the long-term patency following self-expanding nitinol stent implantation in the superficial femoral artery

Doctor K. Miki (Nishinomiya, JP)

Access the full session

Session thumbnail

Poster Session 4 - Peripheral artery disease : endovascular treatment

The Event

ESC Congress 2018

25 August - 29 August 2018

You may be interested in

Congress Presentation

Nuclear cardiology is best for risk assessment

Congress Presentation

CCTA to guide coronary intervention

Webinar

Perioperative use of imaging in patients undergoing noncardiac surgery

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources